← Evidence map

ArticleInflammatory intestinal diseases

Early Symptomatic Improvement Is Informing Long-Term Quality-of-Life Outcomes with Filgotinib Treatment in Ulcerative Colitis: A Post Hoc Analysis of the SELECTION and SELECTIONLTE Trials.

Fumihito Hirai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

Not cited yet

Early Symptomatic Improvement Is Informing Long-Term Quality-of-Life Outcomes with Filgotinib Treatment in Ulcerative Colitis: A Post Hoc Analysis of the SELECTION and SELECTIONLTE Trials. | OpenQuestion